Background: Vitamin D and omega-3 (ω-3) have garnered significant attention in the scientific community due to their ability to exert various non-classical activities on the body, and multifaceted roles in maintaining overall health. Hence, a good understanding of the potential effect of vitamin D and ω-3 in developing and progressing type-1 diabetes mellitus (T1DM) can assist in controlling clinical advancement of the disease. Aims: The current study aimed to experimentally induce T1DM to investigate the role of vitamin D, omega-3, and their combination on the activity of lipid profile, liver enzymes, and antioxidant markers. Materials and methods: A total of 75 young male mice were divided equally into five groups. Initially, T1DM was induced in PC, EG1, EG2, and EG3 by a single high dose of streptozotocin. Mice were treated daily with vitamin D (EG1), ω-3 (EG2), and a combination of both (EG3). After 12 weeks, mice were euthanized and blood was collected to be tested using quantitative specific ELISA kits for the measurement of different blood biomarkers. Results: In comparison to the values of PC, administration of vitamin D for mice of EG1 and ω-3 for mice of EG2 significantly lowered the levels of blood glucose, total cholesterol, LDL, triglyceride, ALT, AST, and MDA, as well as increasing the concentrations of HDL, catalase, GPX, and SOD. The highest ameliorative effect was shown in mice of EG3 that were administered a combination of vitamin D and ω-3. Conclusion: This study may represent the first study in Iraq that investigates the effect of vitamin D and ω-3 on the health status of T1DM in mice. However, the translation of these findings into clinical practice remains a challenge, underscoring the need for continued investigation to fully understand the multifaceted impact of vitamin D on human health.